Thermo Fisher Scientific

D

Quotes are delayed by 15 minutes

Thermo Fisher Scientific (TMO) trades at 706.32 USD, +1.14% today. Over the last 52 weeks it has traded between 435.27 and 711.85.

Thermo Fisher Scientific trades on NYSE under the ticker TMO.

Thermo Fisher Scientific's share price has risen 24.9% over the last 12 months. Since the start of the year it is +21.0%.

$1,000 invested in Thermo Fisher Scientific on 4 November 2016 would be worth $4,957 on 4 November 2026, with its dividends reinvested: 17.4% a year. The same in SPY (the S&P 500) would be $4,305, in QQQ (the Nasdaq 100) $6,524.

Thermo Fisher Scientific's beta is 0.85: its price has moved less than the US market as a whole.

At today's price Thermo Fisher Scientific is worth 261.70B USD. Market cap history

Thermo Fisher Scientific's P/E of 37.2 is near the top of its 5-year range (22.8 to 39.7, median 31.5). Analysts expect faster growth than in recent years, which can explain part of the high P/E. At its usual P/E (31.5 × EPS of 18.99), Thermo Fisher Scientific's fair value is 599.09; the price, 706.32, is ⁦17.9%⁩ above it. P/E history

Thermo Fisher Scientific earned 18.99 a share over the last twelve months. At today's price its shares trade at 37.2 times those earnings. EPS history

In Q3 FY2026, reported on 21 October 2026, revenue was 12.14B USD and net income 1.72B USD. Revenue was +9.1% on the same quarter a year before. EPS of 6.68 beat the 6.40 analysts expected. Every earnings report

Thermo Fisher Scientific reports its next results on 4 February 2027. Earnings and estimates

The shares moved +1.0% on the trading day after its Q3 FY2026 report on 21 October 2026. Every report and its move

Yes: 1.88 USD a share a year at its current rate, a 0.27% yield at today's price. Dividend history and dates

The last ex-dividend date was 15 September 2026, with the dividend paid on 15 October 2026; the next has not been declared yet. Every dividend and its dates

10 of the 13 firms that rate Thermo Fisher Scientific say buy, 3 hold and 0 sell. Their average 12-month price target is 694.27. Forecast and price targets

Thermo Fisher Scientific spent 7.00B USD buying back its own shares over the last twelve months. Its diluted share count fell 1.6% in fiscal year 2025. Buyback history

Over the last twelve months Thermo Fisher Scientific's insiders made 141 open-market sales of 240,314 shares for 140.41M USD, and 0 purchases. The CEO, Marc N. Casper, sold 69,041 of them. Every insider trade

Thermo Fisher Scientific has split its stock 8 times: 2-for-1 (1973), 3-for-2 (1979), 3-for-2 (1984), 3-for-2 (1985), 3-for-2 (1986), 3-for-2 (1993), 3-for-2 (1995), 3-for-2 (1996). The last was a 3-for-2 split on 6 June 1996. A split adds shares without changing what the company is worth.

Thermo Fisher Scientific is in the Healthcare sector, in the Medical - Diagnostics & Research industry. Company profile

Yes. Thermo Fisher Scientific stock is halal by the AAOIFI Shariah screen, on its latest figures: its business (Medical - Diagnostics & Research) is not an excluded activity, its debt is 15.8% of its market value and its cash and interest-bearing investments 2.3% (the limit is 30% each), and its interest income is 2.0% of its revenue (the limit is 5%). Scholars and screening methods differ.

Through a broker that trades on NYSE: open and fund an account, search for TMO and place an order. Arincen compares regulated brokers in its broker reviews.